Amalgam takes over Geetha, LLC, to bolster data science assets

Amalgam Rx., a global platform for healthcare providers and life sciences companies, has ramped up its acquisition game with latest buyout of the assets of Geetha, LLC, an adaptive, conversational AI company.

The acquisition is set to bolster Amalgam’s data science assets, which already include more than 6 million longitudinal data points on million of patients assessed and monitored across the firm’s technology platforms.

Beside, this transaction would also allow Amalgam to take over Geetha’s turnkey psychosocial engine in 40 languages, AI-based chat model, algorithms to accumulate contextual data via chart, and platform to create low-no code virtually customized agents, common sense ontology, and motivational content for a rich understanding of a user’s life. These would be required by the company to respond to the interactions and advanced intervention framework.

It has been reported that Geetha’s Founder, Bharath Sudharsan would join the Amalgam executive team as its Chief Data Scientists and AI Head.

Bharath, while commenting on the recent accomplishment mentioned that Geetha’s next-gen AI when combined with Amalgam’s impressive technology, clinical, and regulatory platform can lead to a deeper level of empathetic engagement, in turn producing lasting change and outcomes.

Meanwhile, Founder and CEO of Amalgam Rx, Ryan Sysko quoted that the firm is thrilled to acquire the AI assets of Geetha along with having Bharath join its team of proficient players.

Ryan added that the future of digital health is in delivering highly scalable, personalized, engaging interventions that adapt over time based on individual’s needs; and in this context, AI and Big Data have emerged out as the foundation of the future.

Parallelly, Suzanne Clough, MD, CMO of Amalgam Rx, cited that incorporating empathy into patient management is deemed to be a highly effective and powerful tool to build trust and improve patient outcomes. And Amalgam and Geetha’s alliance is likely to support the future of quality healthcare.

Source Credit: